A small number of recent studies have linked aspirin’s anti-cancer effects to metabolism; aspirin has been found to inhibit glucose metabolism through the regulation of PDK1 in breast cancer cells [50] and through the regulation of GLUT1 in hepatoma cells [51]. This evidence concerns the gene PDK1 and hepatocellular carcinoma.